What does BIOPOLE ULB - CHARLEROI en abrégé BUC do?

BIOPOLE ULB - CHARLEROI en abrégé BUC is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Public Limited, started on 8 May 2003, 2 establishments.

What is the address of BIOPOLE ULB - CHARLEROI en abrégé BUC?

The registered office of BIOPOLE ULB - CHARLEROI en abrégé BUC is located at Rue Adrienne Bolland 8, 6041 Charleroi.

Is BIOPOLE ULB - CHARLEROI en abrégé BUC still active?

Yes. According to the CBE (30 October 2026) BIOPOLE ULB - CHARLEROI en abrégé BUC is active, legal situation “Normale toestand”, started on 8 May 2003.

Is BIOPOLE ULB - CHARLEROI en abrégé BUC registered on Peppol?

Yes, BIOPOLE ULB - CHARLEROI en abrégé BUC is registered on the Peppol network with ID 0208:0480172170.

What is the enterprise number of BIOPOLE ULB - CHARLEROI en abrégé BUC?

The enterprise number of BIOPOLE ULB - CHARLEROI en abrégé BUC is BE0480172170.

When was BIOPOLE ULB - CHARLEROI en abrégé BUC founded?

BIOPOLE ULB - CHARLEROI en abrégé BUC was founded on 8 May 2003.

Who are the directors of BIOPOLE ULB - CHARLEROI en abrégé BUC?

According to the 2025 annual accounts, the directors of BIOPOLE ULB - CHARLEROI en abrégé BUC are: Michel Coulon, Anne DELVAUX, Isabelle MAZZARA, Daniele CARATI, Françoise MAGERMAN, Anne-Marie SCHAUS, Emery KAREGE, Patrick GOBLET.

Is BIOPOLE ULB - CHARLEROI en abrégé BUC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 May 2003; 5 annual accounts filed, latest fiscal year 2025; 8 directors known from the annual account; 2 establishments in the CBE.

How much profit did BIOPOLE ULB - CHARLEROI en abrégé BUC make in 2025?

BIOPOLE ULB - CHARLEROI en abrégé BUC recorded a loss after taxes of € 24,249 in financial year 2025.

What is the revenue of BIOPOLE ULB - CHARLEROI en abrégé BUC?

As a small company, BIOPOLE ULB - CHARLEROI en abrégé BUC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,302,397.

How much does an employee at BIOPOLE ULB - CHARLEROI en abrégé BUC earn?

The average wage cost per full-time employee at BIOPOLE ULB - CHARLEROI en abrégé BUC was € 61,500 in 2025: staff costs of € 375,059 for 6.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BIOPOLE ULB - CHARLEROI en abrégé BUC have?

According to the 2025 annual accounts, BIOPOLE ULB - CHARLEROI en abrégé BUC has 6.1 full-time equivalents (FTE).

BIOPOLE ULB - CHARLEROI en abrégé BUC (Public Limited)

Dossier BIOPOLE ULB - CHARLEROI en abrégé BUC, printed on 30 October 2026 from databakkes.be/en/0480172170/biopole-ulb-charleroi-en-abrege-buc. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 7 to 6.1.

Financials

Financial year 2025

BIOPOLE ULB - CHARLEROI en abrégé BUC from Charleroi, company number BE0480172170, closed financial year 2025 with a result of € -24,249 after tax. For that financial year BIOPOLE ULB - CHARLEROI en abrégé BUC recorded a gross margin of € 1.3 million and equity of € 4.2 million. Compared with financial year 2024, the result moved from € 142,010 to € -24,249. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 4.2 million

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -24,249

▼ still € 142,010 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 492,237

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -354,701.

People and assets in 2025

Full-time equivalents

6.1

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 375,059

▲ 5% vs 2024

€ 61,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 365,642

▼ 6% vs 2024

Of which on lease € 348,806.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 4.2 million

▼ 27% vs 2024

€ 936,290 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 621,135

▲ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 91,084

▲ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,394,593 Gross margin 2022: € 1,394,593 First fiscal year in the series	€ 1,556,628 Gross margin 2023: € 1,556,628 ▲ 12% vs 2022 (€ 1,394,593) Favourable step	€ 1,398,347 Gross margin 2024: € 1,398,347 ▼ 10% vs 2023 (€ 1,556,628) Unfavourable step	€ 1,302,397 Gross margin 2025: € 1,302,397 ▼ 7% vs 2024 (€ 1,398,347) Unfavourable step	▼ 7%
Profit after taxes	€ 164,529 Profit after taxes 2022: € 164,529 First fiscal year in the series	€ 286,958 Profit after taxes 2023: € 286,958 ▲ 74% vs 2022 (€ 164,529) Favourable step	€ 142,010 Profit after taxes 2024: € 142,010 ▼ 51% vs 2023 (€ 286,958) Unfavourable step	€ -24,249 Profit after taxes 2025: € -24,249 ▼ € 166,259 vs 2024 (€ 142,010) Unfavourable step	▼ € 166,259
Equity	€ 3,114,830 Equity 2022: € 3,114,830 First fiscal year in the series	€ 3,401,788 Equity 2023: € 3,401,788 ▲ 9% vs 2022 (€ 3,114,830) Favourable step	€ 3,543,798 Equity 2024: € 3,543,798 ▲ 4% vs 2023 (€ 3,401,788) Favourable step	€ 4,224,549 Equity 2025: € 4,224,549 ▲ 19% vs 2024 (€ 3,543,798) Favourable step	▲ 19%
Total debts	€ 7,511,633 Total debts 2022: € 7,511,633 First fiscal year in the series	€ 7,061,901 Total debts 2023: € 7,061,901 ▼ 6% vs 2022 (€ 7,511,633) Favourable step	€ 6,907,015 Total debts 2024: € 6,907,015 ▼ 2% vs 2023 (€ 7,061,901) Favourable step	€ 5,427,998 Total debts 2025: € 5,427,998 ▼ 21% vs 2024 (€ 6,907,015) Favourable step	▼ 21%
Cash	€ 765,485 Cash 2022: € 765,485 First fiscal year in the series	€ 303,304 Cash 2023: € 303,304 ▼ 60% vs 2022 (€ 765,485) Unfavourable step	€ 638,943 Cash 2024: € 638,943 ▲ 111% vs 2023 (€ 303,304) Favourable step	€ 492,237 Cash 2025: € 492,237 ▼ 23% vs 2024 (€ 638,943) Unfavourable step	▼ 23%
Land & buildings	€ 7,730,674 Land & buildings 2022: € 7,730,674 First fiscal year in the series	€ 7,234,428 Land & buildings 2023: € 7,234,428 ▼ 6% vs 2022 (€ 7,730,674) Unchanged	€ 6,738,193 Land & buildings 2024: € 6,738,193 ▼ 7% vs 2023 (€ 7,234,428) Unchanged	€ 6,245,250 Land & buildings 2025: € 6,245,250 ▼ 7% vs 2024 (€ 6,738,193) Unchanged	▼ 7%
Retained profit	€ -759,420 Retained profit 2022: € -759,420 First fiscal year in the series	€ -472,462 Retained profit 2023: € -472,462 ▲ € 286,958 vs 2022 (€ -759,420) Favourable step	€ -330,452 Retained profit 2024: € -330,452 ▲ € 142,010 vs 2023 (€ -472,462) Favourable step	€ -354,701 Retained profit 2025: € -354,701 ▼ € 24,249 vs 2024 (€ -330,452) Unfavourable step	▼ € 24,249
Bank debt	€ 6,647,989 Bank debt 2022: € 6,647,989 First fiscal year in the series	€ 6,092,595 Bank debt 2023: € 6,092,595 ▼ 8% vs 2022 (€ 6,647,989) Favourable step	€ 5,841,559 Bank debt 2024: € 5,841,559 ▼ 4% vs 2023 (€ 6,092,595) Favourable step	€ 4,236,426 Bank debt 2025: € 4,236,426 ▼ 27% vs 2024 (€ 5,841,559) Favourable step	▼ 27%
Balance sheet total	€ 10,626,463 Balance sheet total 2022: € 10,626,463 First fiscal year in the series	€ 10,463,689 Balance sheet total 2023: € 10,463,689 ▼ 2% vs 2022 (€ 10,626,463) Unchanged	€ 10,450,813 Balance sheet total 2024: € 10,450,813 Unchanged (€ 10,463,689) Unchanged	€ 9,652,548 Balance sheet total 2025: € 9,652,548 ▼ 8% vs 2024 (€ 10,450,813) Unchanged	▼ 8%
Employees (FTE)	7.5 Employees (FTE) 2022: 7.5 First fiscal year in the series	7 Employees (FTE) 2023: 7 ▼ 0.5 vs 2022 (7.5) Unchanged	6.6 Employees (FTE) 2024: 6.6 ▼ 0.4 vs 2023 (7) Unchanged	6.1 Employees (FTE) 2025: 6.1 ▼ 0.5 vs 2024 (6.6) Unchanged	▼ 0.5

Key figures of BIOPOLE ULB - CHARLEROI en abrégé BUC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOPOLE ULB - CHARLEROI en abrégé BUC?

What happened at BIOPOLE ULB - CHARLEROI en abrégé BUC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Michel Coulon stepped down as director. NBB
2031 Isabelle MAZZARA stepped down as director. NBB
2027 Anne-Marie SCHAUS stepped down as director. NBB
2027 Anne DELVAUX stepped down as director. NBB
2027 Daniele CARATI stepped down as director. NBB
2027 Françoise MAGERMAN stepped down as director. NBB
2027 Emery KAREGE stepped down as director. NBB
Jun 29, 2026 New annual accounts for financial year 2025: loss of € 24,249 (▼ € 166,259 vs 2024). Source: NBB ↗

In short

From € 164,529 profit in 2022 to € 24,249 loss in 2025.

Paid € 7,239 in corporate taxes since 2022.

Best year ever: 2023, with € 286,958 profit.

On average € 213,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Michel Coulon

Director

Also active at: Palais des Beaux Arts de Charleroi, Brussels South Charleroi BioPark Dev, Centre universitaire Zénobe Gramme

since 2025 · until 2031

Anne DELVAUX

Managing director

since 2021 · until 2027

Isabelle MAZZARA

Chairman of the board

Also active at: PARTENA - SECRETARIAT SOCIAL D'EMPLOYEURS - PARTENA - SOCIAAL SECRETARIAAT VOOR werkgevers, F9 Languages in Brussels, C. L. U. INVEST, PARTENA BUSINESS SOLUTIONS

since 2025 · until 2031

Daniele CARATI

Director

since 2021 · until 2027

Françoise MAGERMAN

Managing director

Also active at: IMPACTHEO

since 2021 · until 2027

Anne-Marie SCHAUS

Director

since 2021 · until 2027

Emery KAREGE

Director

since 2021 · until 2027

Patrick GOBLET

Director

Also active at: Centre d'accompagnement de projets innovants, DIGINNOV

since 2021 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Adrienne Bolland 8

6041 Charleroi

2.177.484.407

Avenue Georges Lemaitre 19

6041 Charleroi

Active since 24 March 2009

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CellCarta Biosciences

€ 6 million gross margin · 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0480.172.170

VAT number

BE 0480.172.170

Registered office

Rue Adrienne Bolland 8, 6041 Charleroi

Names & denominations

BIOPOLE ULB - CHARLEROI en abrégé BUC

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

8 May 2003

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Overige zakelijke dienstverlening, neg

Bedrijvencentra

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOPOLE ULB - CHARLEROI en abrégé BUC

Warning lights

Financials

What happened to BIOPOLE ULB - CHARLEROI en abrégé BUC?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions